ijms-logo

Journal Browser

Journal Browser

Molecular Insights into Hepatocellular Carcinoma: From Carcinogenesis to Liver Transplantation

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 30 September 2025 | Viewed by 93

Special Issue Editor


E-Mail Website
Guest Editor
Department of Surgery, The University of Hong Kong, Hong Kong, China
Interests: molecular mechanisms of carcinogenesis; metastasis and chemoresistance of hepatocellular carcinoma; molecular targets linking acute phase hepatic injury; late phase hepatocellular carcinoma recurrence; liver transplantation

Special Issue Information

Dear Colleagues,

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, arising from complex molecular mechanisms involving chronic inflammation, cirrhosis, viral hepatitis, genetic and epigenetic alterations, and metabolic dysfunction. Despite advances in early detection and treatment, HCC remains a significant clinical challenge due to its high recurrence rate and limited therapeutic options for advanced stages. This Special Issue will explore the comprehensive molecular pathogenesis of HCC, from early carcinogenic events to immune escape, progression, metastasis, therapy responses, and resistance to liver transplantation. By integrating cutting-edge research, this Special Issue aims to bridge fundamental science and clinical applications, fostering advancements in HCC understanding and precision oncology. We invite submissions of original research and review articles that contribute to this Special Issue, “Molecular Insights into Hepatocellular Carcinoma: From Carcinogenesis to Liver Transplantation”.

Your contributions are indispensable to the success of this initiative.

Dr. Kevin Tak-Pan Ng
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hepatocarcinogenesis
  • molecular pathogenesis
  • tumor microenvironment
  • metabolic dysfunction-associated fatty liver disease (MAFLD)
  • metastasis
  • genetic and epigenetic alterations
  • biomarkers
  • precision oncology
  • targeted therapy
  • immunotherapy
  • therapy resistance
  • immune escape
  • tumor recurrence
  • transplant oncology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

23 pages, 1652 KiB  
Review
Emerging Roles of C-C Motif Ligand 11 (CCL11) in Cancers and Liver Diseases: Mechanisms and Therapeutic Implications
by Jiaqi Wang, Kwan Man and Kevin Tak-Pan Ng
Int. J. Mol. Sci. 2025, 26(10), 4662; https://doi.org/10.3390/ijms26104662 - 13 May 2025
Abstract
C-C motif ligand 11 (CCL11) is a multifunctional chemokine that regulates immunity, angiogenesis, and tissue remodeling. In addition to its allergic inflammation role, CCL11 exhibits context-dependent dual functions in relation to cancer progression. In liver diseases, it mediates injury, fibrosis, and inflammation while [...] Read more.
C-C motif ligand 11 (CCL11) is a multifunctional chemokine that regulates immunity, angiogenesis, and tissue remodeling. In addition to its allergic inflammation role, CCL11 exhibits context-dependent dual functions in relation to cancer progression. In liver diseases, it mediates injury, fibrosis, and inflammation while serving as a disease biomarker. This review systematically examines CCL11–receptor interactions and their immunomodulatory mechanisms in cancers and hepatic pathologies. We highlight CCL11’s therapeutic potential as both a prognostic marker and immunotherapeutic target. By integrating molecular and clinical insights, this work advances the understanding of CCL11’s pathophysiological roles and facilitates targeted therapy development. Full article
Show Figures

Figure 1

Back to TopTop